NCT03511157

Brief Summary

This study proposes ischemic preconditioning (IPC) as a novel intervention to improve walking distance in patients with intermittent claudication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 9, 2018

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 27, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

June 14, 2018

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2022

Completed
Last Updated

December 14, 2022

Status Verified

December 1, 2022

Enrollment Period

4.5 years

First QC Date

April 9, 2018

Last Update Submit

December 13, 2022

Conditions

Keywords

ischemic preconditioning

Outcome Measures

Primary Outcomes (1)

  • Peak walking time

    Subjects will be placed on a motorized treadmill and peak walking time will be recorded in seconds.

    2 weeks

Secondary Outcomes (2)

  • Muscle Fatigue

    2 weeks

  • Claudication onset time

    2 weeks

Study Arms (2)

Ischemic Preconditioning

EXPERIMENTAL

A standard blood pressure cuff will be placed on the right or left thigh, depending on the affected side, to occlude blood flow. The cuff will be inflated to 225 mmHg to prevent blood flow. Each session will consist of 4 cycles of 5 minute IPC applications, followed by 5 minutes of reperfusion for a total of 35 minutes.

Other: Ischemic Preconditioning

Control

SHAM COMPARATOR

The sham intervention protocol will be identical to the IPC protocol except blood flow to the affected leg is unchanged as cuff pressure will be raised to between the venous and diastolic pressures

Other: Control Group

Interventions

See Ischemic Preconditioning Experimental group description

Ischemic Preconditioning

See Control group description

Control

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • between ages of 18-80
  • able to give informed consent
  • presence of vascular disease with intermittent claudication

You may not qualify if:

  • age \< 18 or \>80
  • unable to give informed consent
  • presence of vascular disease with leg pain at rest, ischemic ulceration, or gangrene
  • pregnancy
  • unable to walk on a treadmill
  • unable to perform or tolerate ischemic preconditioning
  • unable to follow commands
  • exercise capacity limited by symptoms of angina, congestive heart failure, chronic obstructive pulmonary disease, or arthritis to be determined by PI
  • patients who have undergone vascular surgery or endovascular surgery in the previous year on the affected leg
  • history of major lower extremity amputation
  • history of major psychiatric disorder
  • history of uncontrolled hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Froedtert and the Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Intermittent ClaudicationPeripheral Arterial DiseasePeripheral Vascular Diseases

Interventions

Ischemic PreconditioningControl Groups

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsAtherosclerosisArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsInvestigative TechniquesEpidemiologic Research DesignEpidemiologic MethodsResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 9, 2018

First Posted

April 27, 2018

Study Start

June 14, 2018

Primary Completion

December 13, 2022

Study Completion

December 13, 2022

Last Updated

December 14, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations